XBP1 and neoplasm: Mechanistically, emerging epigenetic regulators like the LINC00963/miR-320a/XBP1 axis [54] and ZNF263-mediated super-enhancer activation [55] provide novel molecular insights into tumor heterogeneity and targeted intervention.